Company Overview - Titan Technology Co., Ltd. is located at 89 Shilong Road, Xuhui District, Shanghai, established on October 18, 2007, and listed on October 30, 2020 [1] - The company provides integrated technical solutions for scientific services, including research reagents, biological consumables, analytical consumables, laboratory instruments, smart laboratory equipment, research information technology, specialty chemicals, and related comprehensive technical services [1] Financial Performance - For the first half of 2025, Titan Technology achieved operating revenue of 1.219 billion yuan, a year-on-year decrease of 12.70%, while the net profit attributable to shareholders increased by 91.55% to 9.7652 million yuan [2] - The company has distributed a total of 86.6205 million yuan in dividends since its A-share listing, with 40.1089 million yuan distributed over the past three years [3] Stock Performance - As of October 14, Titan Technology's stock price decreased by 2.04% to 24.53 yuan per share, with a market capitalization of 4.034 billion yuan [1] - Year-to-date, the stock price has increased by 35.00%, with a slight increase of 0.74% over the last five trading days, a decrease of 3.12% over the last 20 days, and an increase of 0.33% over the last 60 days [1] Shareholder Information - As of June 30, the number of shareholders increased by 12.61% to 7,718, while the average circulating shares per person decreased by 11.19% to 21,305 shares [2] Industry Classification - Titan Technology belongs to the Shenwan industry classification of basic chemicals - chemical products - other chemical products, and is associated with concepts such as small-cap stocks, pension concepts, margin financing, and buybacks [2]

Group 1 - Titan Technology's stock price has declined for eight consecutive days, with a total drop of 19.16%, currently trading at 24.38 CNY per share and a market capitalization of 4.009 billion CNY [1] - The company, established in October 2007 and listed in October 2020, provides integrated technical solutions for scientific services, including research reagents, biological consumables, analytical consumables, laboratory instruments, and specialized chemicals [1] - The revenue composition of Titan Technology includes 25.08% from proprietary specialty chemicals, 20.48% from proprietary high-end reagents, and 15.65% from third-party research instruments and consumables [1] Group 2 - Rongtong Fund holds 1.161 million shares of Titan Technology in its Rongtong Healthcare Industry Mixed Fund A/B, representing 3.28% of the fund's net value, making it the ninth largest holding [2] - During the eight-day decline, the fund has incurred a floating loss of approximately 670.98 thousand CNY [2] - The Rongtong Healthcare Industry Mixed Fund A/B has achieved a year-to-date return of 22.05% and a one-year return of 33.89% [2] Group 3 - The fund managers of Rongtong Healthcare Industry Mixed Fund A/B are Wan Minyuan and Liu Xiyang, with Wan having a tenure of nearly 10 years and a best fund return of 157.54% during his management [3] - Liu Xiyang has been managing the fund for about 1.5 years, with a best fund return of 4.17% during his tenure [3]